 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
5-22-2023
Insider Buy |
Assaf Oron
Chief Business Officer |
$0.27
CAGR »
|
$871.74
3,192 shares |
7-28-2021
Insider Buy |
Alan Charles Moses
Director |
$4.00
CAGR »
|
$20,000.00
5,000 shares |
7-28-2021
Insider Buy |
Paul J. Sekhri
Director |
$4.00
CAGR »
|
$50,000.00
12,500 shares |
7-28-2021
Insider Buy |
Russell Greig
Director |
$4.00
CAGR »
|
$15,000.00
3,750 shares |
7-28-2021
Insider Buy |
Marina Wolfson
SVP of Finance & Operations |
$4.00
CAGR »
|
$15,000.00
3,750 shares |
12-19-2019
Insider Buy |
Erez Chimovits
Director and >10% Owner |
$8.90
CAGR »
|
$35,615.00
4,000 shares |
12-19-2019
Insider Buy |
Israel Biofund GP Limited Partnership Orbimed
Director and >10% Owner |
$8.90
CAGR »
|
$35,615.00
4,000 shares |
12-11-2019
Insider Buy |
Israel Biofund GP Limited Partnership Orbimed
Director and >10% Owner |
$8.85
CAGR »
|
$77,918.00
8,800 shares |
12-11-2019
Insider Buy |
Erez Chimovits
Director and >10% Owner |
$8.85
CAGR »
|
$77,918.00
8,800 shares |
12-9-2019
Insider Buy |
Erez Chimovits
Director and >10% Owner |
$8.40
CAGR »
|
$85,646.00
10,200 shares |
12-9-2019
Insider Buy |
Israel Biofund GP Limited Partnership Orbimed
Director and >10% Owner |
$8.40
CAGR »
|
$85,646.00
10,200 shares |
Also See: Institutional Holders of PHGE
Also See: SEC filings
Below we present the annualized performance delivered by PHGE stock since 5-22-2023 (the date of the most recent
insider purchase). The performance of the investment from the time PHGE insider buying occurred is the ultimate
test of whether insiders were right about PHGE being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
05/23/2023 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$0.28 |
|
| End price/share: |
$0.35 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
24.56% |
|
| Annualized Gain: |
26.44% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$12,456.00 |
|
| Years: |
0.93 |
|
PHGE Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent PHGE insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding PHGE
|
|
Free PHGE Email Alerts:
